345
Views
33
CrossRef citations to date
0
Altmetric
Articles

A novel implementation of water recovery from whey: “forward–reverse osmosis” integrated membrane system

, , , , , & show all
Pages 786-799 | Received 28 Feb 2012, Accepted 10 May 2012, Published online: 06 Jun 2012
 

Abstract

As a result of its emerging contribution to water recovery and clean water production, forward osmosis (FO) in integrated membrane system has recently especially been preferred by research communities on membrane science and desalination technology. In this study, the effectiveness of FO reverse osmosis (RO) integrated membrane system in whey dewatering was investigated in laboratory scale experiments in which FO and RO were utilized for whey concentration and water recovery, respectively. FO experiments were carried out at different conditions of cross-flow rate, temperature, membrane kind, membrane orientation mode, and microfiltration (MF) pretreatment. A single-step RO system was applied for water recovery from the FO draw solution. In the FO process, about 1.6 L water of 3 L whey was withdrawn into 3 M NaCl draw solution during 6 h operating time, and a sufficiently high performance in whey concentration was obtained, with the solid content being increased from 6.8 to 14.3%. However, the process resulted in a high salt permeation into the whey, in addition to some soluble organics being permeated into the draw. RO process are operated with relatively low performances due to excessive salt concentration of the FO draw solutions, which indicates that there is a need for RO implementation in two or three sequential levels for achieving an absolute success in the water recovery from whey. Despite the fact that MF pretreatment to some extent decreased the FO performance, it could be used for directly productive activities intended to recover fats from whey. Results have proved that prior to whey powder production, the integrated system could be effectively employed for whey concentrations up to a solid content of 25–35%. Accordingly, FO–RO system can be utilized as a novel alternative in concentrating whey compared to ultrafiltration-RO combined system widely used worldwide. However, before practical implementation of the system, an optimization between alleviating the salt concentration in FO draw and multi-step RO implementation should have to be considered concurrently with the economics of the investment.

Acknowledgments

This study was financially supported by a national project (No: 109Y300) by the TUBITAK, the Scientific and Technological Research Council of Turkey.The authors would like to thank the Cayirova Milk&Milk Products Inc., especially to Mr Seyhmuz Aslan and Ms Neslihan Genal, for the cheese whey supplement. Thanks are also due to Hydration Technologies Inc., and Hydranautics Inc., for the membrane supplements.

Notes

Presented at the International Conference on Desalination for the Environment, Clean Water and Energy, European Desalination Society, 23–26 April 2012, Barcelona, Spain

aAt the best experimental conditions–membrane type: FO membrane, operation mode: reverse mode, draw solution: 3 M NaCl, temperature: 25 ± 0.5°C, cross-flow rate: 300 L h−1 (0.5 m s−1), process time: 360 min, each volume of feed and draw solutions: 3 L.

a0.5 M NaCl solution was also purified by RO process to compare the effectiveness of RO filtrations of FO draw solutions. Water flux of the solution was determined as 43.62 L m−2 h−1, while conductivity, Cl, and osmolality in the feed and permeate were determined as 42,900 and 132 mS cm−1, 17,725 and 55 mg L−1, and 882 and 16 mmol kg−1, respectively, of which rejection rates were about 99.7, 99.7 and 98.2%, respectively.

BAs the draw solution of FO process in normal operation mode used in the FO operation completely clogged the pores of the RO membrane at about 45 min of the experiment, the results are the values measured in the sample taken at that time.

CAs there was no water permeation in the RO experiment, data for the draw solution of FO process in reverse operation mode which used CPA-3 membrane could not be obtained.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.